BDX|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'25 | $2.81 | - | - |
| Q3'26 | $3.17 | $3.23 | +1.8% |
| Q2'26 | $2.77 | $2.90 | +4.5% |
| Q1'26 | $3.31 | $2.91 | -12.1% |
| Q3'25 | $3.91 | $3.96 | +1.1% |
| Q2'25 | $3.40 | $3.68 | +8.2% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'25 | $5.2B | - | - |
| Q3'26 | $4.9B | $5.0B | +1.0% |
| Q2'26 | $4.7B | $4.7B | -0.0% |
| Q1'26 | $5.5B | $5.3B | -5.0% |
| Q3'25 | - | $5.9B | - |
| Q2'25 | - | $5.5B | - |
BDX|Monthly Returns
Market Data
BDX Stock Snapshot
- Market cap
- 49.16B
- P/E ratio
- 52.2
- Day range
- $181.28 – $186.63
- News sentiment
- 58/100 · Neutral
- Analyst target
- $195.67 (+5.4%)
- Consensus
- Hold · 23 analysts
BDX sits in the upper part of its 52-week range with the technical picture unresolved. Institutional coverage is thorough here, so shifts in analyst expectations show up in price quickly.
Reverse DCF
What growth is priced into BDX?
At today's price, Becton, Dickinson and Company needs to grow free cash flow about 3.8% a year for the next 10 years to justify its valuation at a 6.59% cost of capital. Over its actual history it has compounded free cash flow at 7.2% a year, so the market is asking for 3.4 percentage points below its own delivered rate. On that basis BDX looks priced below what its own growth record supports.
- Implied FCF growth
- 3.8%
- Historical FCF CAGR
- 7.2%
- Growth gap
- -3.4 pts
- Verdict
- CHEAP
- Discount rate (WACC)
- 6.59%
- Beta
- 0.62
Behaviour On Record
What BDX's own history says about today's numbers
- Realized volatility (21d)
- 23.2% 71st pct
- Below its peak
- -18.2%
- vs 200-day average
- +15.1%
- Up days (1y)
- 48%
Becton, Dickinson and Company is currently running 23.2% annualised volatility over the last 21 sessions. Measured against BDX's own 13 years of daily returns rather than a market-wide average, that is the 71st percentile — a little above its own norm, against a typical reading of 18.8%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
BDX is trading -18.2% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -16.9%, and the deepest was -34.0% in 2025. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.
Price sits +15.1% from its 200-day moving average. Against every other day in its history, that gap ranks at the 97th percentile — a wider gap than this stock usually carries. Over the past year BDX closed higher on 48% of sessions, and it is currently 3 sessions into a rising streak.
On September specifically: over 14 years of records, BDX finished the month higher 2 of 14 times, with a median return of -1.2% and an average of -2.2%. Its strongest month historically has been July at +4.0% on average, its weakest September at -2.2%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: BDX has opened more than 2% away from the prior close in 72 of 3,268 sessions (2.2% of the time), with the largest gaps running +35.8% and -8.9%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
Across the last 4 dated reports on file, BDX moved an average of 1.9% in the session after earnings, closing higher 2 of those 4 times, with a median move of -0.3% and a largest of -3.6%.
All figures computed from 3,269 daily closes between 2013-09-16 and 2026-09-15, split-adjusted, recomputed daily. Percentiles are against BDX's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of BDX's sector?
Becton, Dickinson and Company sits in the Health Care sector, currently ranked 3rd of 11 GICS sectors by relative-strength rotation score (leading).
- Sector rank
- #3 of 11
- Sector state
- Leading
- Sector rotation score
- 80
Analyst Rating Changes
Are analysts turning bullish or bearish on BDX?
B of A Securities most recently reiterated its rating on Becton, Dickinson and Company to Neutral on Aug 31, 2026 with a price target of $200 (from $185). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.
- Latest action
- B of A Securities — Neutral
- 90-day upgrades
- 0
- 90-day downgrades
- 0
- Net rating momentum
- 0
BDX Competitive Positioning
- BDXyou're hereBecton, Dickinson and Company$49.2B-0.10%
- ISRGIntuitive Surgical, Inc.$131.8B+0.20%
- RMDResMed Inc.$31.5B-0.05%
- BAXBaxter International Inc.$12.4B+0.04%
- COOThe Cooper Companies, Inc.$10.4B+0.94%
- TFXTeleflex Incorporated$5.5B-0.01%